Resource Use Among Nonvalvular Atrial Fibrillation Patients
This study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.
Read More
Annual Stroke Costs to Health Plans Among Atrial Fibrillation Patients
An incidence-based model was developed to estimate the annual ischemic and hemorrhagic stroke–related healthcare costs to a hypothetical US health plan with 1 million enrollees.
Read More